Effective Date :
3/13/2020 12:00:00 AM
Authority :
Section 19(a)(3) of the District of Columbia Pharmacist and Pharmacy Regulation Act of 1980, effective September 16, 1980 (D.C. Law 3-98; D.C. Official Code § 47-2885.18(a)(3) (2015 Repl.)); the District of Columbia Uniform Controlled Substances Act of 1981, effective August 5, 1981 (D.C. Law 4-29; D.C. Official Code §§ 48-901.01 et seq., and § 48-903.01 (2014 Repl.)); Mayor’s Order 98-48, dated April 15, 1998; Section 4902 of the Fiscal Year 2002 Budget Support Act of 2001, effective October 3, 2001 (D.C. Law 14-28; D.C. Official Code § 7-731 (2018 Repl.)); Section 15 of the District of Columbia Drug Manufacture and Distribution Licensure Act of 1990, effective June 13, 1990 (D.C. Law 8-137; D.C. Official Code § 48-714(a) (2014 Repl.)); Section 401 of the Opioid Overdose Treatment and Prevention Omnibus Act of 2018, effective April 11, 2019 (D.C. Law 22-288; D.C. Official Code § 48-853.03a (2019 Supp.)); and Mayor’s Order 98-88, dated May 29, 1998
Source :
Final Rulemaking published at 33 DCR 1046, 1047 (February 21, 1986); as amended by Final Rulemaking published at 54 DCR 12298 (December 21, 2007); as amended by Final Rulemaking published at 67 DCR 2798 (March 13, 2020).
Editor's Note :